[R01] Imaging Feedback for Histotripsy Renal Tumor Ablation
Ente: National Institute of Biomedical Imaging and Bioengineering
Scadenza: 2029-03-31
Importo max: $44,589
Paese: US
Descrizione
PROJECT SUMMARY: Renal cell carcinoma (RCC) is the sixth most common cancer in the United States, with
~ 82k new diagnoses estimated for 2023. Surgery is the preferred option for initial management of RCC, but the
number of patients who qualify is reduced each year due to the aging, comorbid populat
Settori: National Institute of Biomedical Imaging and Bioengineering
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.